
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered ... Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.045 | -15.4631379962 | 13.225 | 13.425 | 11.18 | 253899 | 13.06278281 | CS |
4 | -0.28 | -2.44328097731 | 11.46 | 13.425 | 10.96 | 183108 | 12.46407946 | CS |
12 | -1.49 | -11.7600631413 | 12.67 | 13.91 | 10.3537 | 254686 | 12.36240225 | CS |
26 | -6.49 | -36.7289190719 | 17.67 | 17.93 | 10.3537 | 258334 | 13.73423146 | CS |
52 | -4.24 | -27.4967574578 | 15.42 | 22.188 | 10.3537 | 290050 | 15.63114632 | CS |
156 | 1.16 | 11.5768463074 | 10.02 | 22.188 | 4.81 | 147032 | 13.99549126 | CS |
260 | 1.55 | 16.0955347871 | 9.63 | 33.01 | 4.03 | 120714 | 15.92208973 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions